글로벌 식욕부진제 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모                              

식욕억제제는 뇌에 작용하는 식욕억제제입니다. 이 약물은 포만감을 조절하는 시상하부와 뇌의 변연계를 자극합니다. 비만은 식욕억제제로 치료할 수 있습니다. 세계보건기구 보고서에 따르면 2017년 전 세계적으로 약 6억 5천만 명과 5세 미만 어린이 4천 1백만 명이 비만이었습니다. 비만 치료에 사용되는 식욕억제제 약물에는 로카세린ER, 날트렉손/부프로피온 ER, 올리스타트, 리라글루티드, 로카세린, 펜테르민/토피라메이트 ER이 있습니다. 많은 약물이 FDA에서 비만 치료를 위해 허가를 받았기 때문에 식욕억제제 시장은 향후 몇 년 동안 증가할 것으로 예상됩니다.

Data Bridge Market Research는 식욕 부진제 시장이 2021년에 0.82억 달러 규모였으며 2029년까지 1.22억 달러에 도달할 것으로 예상하고 2022년에서 2029년까지의 예측 기간 동안 5.12%의 CAGR을 기록할 것으로 분석했습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화

Market Definition

Anorexiants, often known as appetite suppressants, are a type of medication used to treat obesity. This medicine reduces food consumption by acting on the brain to inhibit appetite. Obesity is a long-term condition in which an individual's extra body fat builds up to the point where it threatens his or her health. When people consume more calories than they expend over time, this occurs. Anorexiants are CNS stimulants that reduce appetite and are available as immediate and extended-release tablets. These are prescription medications that should be used in conjunction with a low-calorie diet and regular exercise.

Anorexiants Market Dynamics

Drivers

• Increasing prevalence of obesity

The increasing prevalence of obesity across the globe will fuel industry growth. Obesity is a condition in which a person's body fat levels have accumulated to the point where they are causing health problems. When people consume more calories than they expend over time, this occurs. Obesity raises the risk of chronic diseases such breast cancer, colon cancer, type 2 diabetes, endometrial cancer, cardiovascular disease, and musculoskeletal issues. Obesity afflicted 650 million people and 340 million children and adolescents worldwide in 2016, according to the World Health Organization. This condition can be avoided by changing one's lifestyle. When a person's body mass index (BMI) exceeds 30, that individual is called obese. Inactivity, genetics, family lifestyle, bad nutrition, drugs, age, and pregnancy can all contribute to obesity.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of anorexiants market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, surging geriatric population and rise in the number of government initiatives to spread awareness will result in the expansion of anorexiants market. Along with this, sedentary lifestyle of people and increasing level of disposable income will enhance the growth rate of the market. Increasing availability of branded drugs and limited physical inactivity are the factors due to which market is anticipated to grow rapidly during the forecast period of 2022-2029.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the anorexiants market’s growth.

Moreover, the market's growth is fueled by rising technological advancement and emerging new markets. These factors will provide beneficial opportunities for the anorexiants market growth.

Restraints/Challenges

On the other hand, high cost of drug development and distribution will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and dearth of skilled professionals will challenge the anorexiants market. Additionally, lack of awareness among people and side effects linked with the anorexiants such as diarrhea, tachycardia, headache, myalgia, insomnia, nausea, vomiting and others will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This anorexiants market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anorexiants market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Anorexiants market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Anorexiants Market

Obese persons have faced difficulties as a result of the COVID-19 shutdown. During this time, the lifestyle was drastically altered: nutrition, activity, and sleep habits, home office, child care, and social isolation. All of these changes could have contributed to tension and anxiety. It has previously been shown that high levels of perceived stress are linked to a predilection for sweet and fatty foods. Binge eating disorder, which is characterized by compulsive overeating or ingesting abnormal amounts of food while feeling unable to stop and a loss of control, has become more common in this situation. Patients with binge eating problems may have been particularly sensitive to the effects of lockdown, necessitating immediate medical attention. Hence, all these factors lead to the high demand of anorexiants market during pandemic period.

Global Anorexiants Market Scope

The anorexiants market is segmented on the basis of indication, drugs class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

• Catecholamines Anorexiants
• Serotonin Anorexiants

Indication

• ADHD
• Dravet Syndrome
• Lennox-Gastaut Syndrome
• Obesity
• Weight Loss
• Others

Route of Administration

• Oral
• Subcutaneous
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Anorexiants Market Regional Analysis/Insights

The anorexiants market is analysed and market size insights and trends are provided by country, indication, drugs class, route of administration, end-users and distribution channel as referenced above.

The countries covered in the anorexiants market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the anorexiants market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing prevalence of obesity and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, growing presence of major key players and rise in adoption of newer technologies will further propel the market’s growth rate in this region.

아시아 태평양 지역은 이 지역의 가처분 소득 수준이 급증함에 따라 2022-2029년 예측 기간 동안 가장 빠르게 성장할 지역이 될 것으로 예상됩니다. 또한, 의료 인프라의 개발과 제네릭 의약품 제조업체의 증가는 이 지역의 시장 성장률을 더욱 촉진할 것입니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 식욕 부진제 시장 점유율 분석

식욕부진제 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우위가 있습니다. 위에 제공된 데이터 포인트는 식욕부진제 시장과 관련된 회사의 초점에만 관련이 있습니다.

식욕 부진제 시장에서 활동하는 주요 업체는 다음과 같습니다.

• F. 호프만-라 로슈 유한회사(스위스)
• 마일런 NV(미국)
• Teva Pharmaceutical Industries Ltd. (아일랜드)
• 사노피(프랑스)
• 파이저 주식회사(미국)
• GlaxoSmithKline plc (영국)
• 노바티스 AG(스위스)
• 머크앤코(미국)
• 아스트라제네카(영국)
• 존슨앤존슨 프라이빗 리미티드(미국)
• Aurobindo Pharma(인도)
• 시플라 주식회사(미국)
• 라넷(미국)
• Bausch Health Companies Inc. (캐나다)
• Sun Pharmaceutical Industries Ltd. (인도)
• Novo Nordisk A/S(덴마크)
• Currax Pharmaceuticals LLC(미국)
• 에자이 주식회사(일본)
• 다케다제약 주식회사(일본)

SKU-53390